Tag Archives: Bloomberg-Kimmel Institute for Cancer Immunotherapy

Immuno-oncology conundrum: Stage IV patient wants cutting-edge immunotherapy, but his oncologist says no. My personal take.

The News: Four women had an extremely rare, aggressive and fatal type of ovarian cancer. There was no standard treatment. All four women, who lived in different countries, asked their… Read more »